Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical Reviews in Allergy & Immunology
Published in: Clinical Reviews in Allergy & Immunology 2/2007

01-04-2007

Orthopedic Involvement in Antiphospholipid Syndrome

Authors: Alexander Gorshtein, Yair Levy

Published in: Clinical Reviews in Allergy & Immunology | Issue 2/2007

Login to get access

Abstract

Antiphospholipid syndrome (APS) is a common autoimmune disease, manifested by vascular thrombosis and fetal loss in the presence of antiphospholipid antibodies. Orthopedic involvement is a relatively novel and underrecognized feature of APS. In this article we review the association of primary, secondary, and catastrophic APS with diverse orthopedic conditions, including osteonecrosis in adult and pediatric patients, bone marrow necrosis, nontraumatic fractures, and some other disorders.
Literature
1.
Hughes GR (1983) Thrombosis, abortion, cerebral disease, and the lupus anticoagulant. Br Med J 287:1088–1089
2.
McNeil HP, Simpson RJ, Chesterman CN, Krilis SA (1990) Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 87:4120–4124PubMedCrossRef
3.
Oshiro BT, Silver RM, Scott JR, Yu H, Branch DW (1996) Antiphospholipid antibodies and fetal death. Obstet Gynecol 87:489–493PubMedCrossRef
4.
Asherson RA (1992) The catastrophic antiphospholipid syndrome. J Rheumatol 19:508–512PubMed
5.
Vasoo S, Sangle S, Zain M, D’Cruz D, Hughes G (2005) Orthopaedic manifestations of the antiphospholipid (Hughes) syndrome. Lupus 14:339–345PubMedCrossRef
6.
7.
Mitchell DG, Rao VM, Dalinka MK et al (1987) Femoral head avascular necrosis: correlation of MR imaging, radiographic staging, radionuclide imaging, and clinical findings. Radiology 162:709–715PubMed
8.
Genez BM, Wilson MR, Houk RW et al (1988) Early osteonecrosis of the femoral head: detection in high-risk patients with MR imaging. Radiology 168:521–524PubMed
9.
Seleznick MJ, Silveira LH, Espinoza LR (1991) Avascular necrosis associated with anticardiolipin antibodies. J Rheumatol 18:1416–1417PubMed
10.
Vela P, Batlle E, Salas E, Marco P (1991) Primary antiphospholipid syndrome and osteonecrosis. Clin Exp Rheumatol 9:545–546PubMed
11.
Tektonidou MG, Malagari K, Vlachoyiannopoulos PG, Kelekis DA, Moutsopoulos HM (2003) Asymptomatic avascular necrosis in patients with primary antiphospholipid syndrome in the absence of corticosteroid use: a prospective study by magnetic resonance imaging. Arthritis Rheum 48:732–736PubMedCrossRef
12.
Dubois EL, Cozen L (1960) Avascular (aseptic) bone necrosis associated with systemic lupus erythematosus. JAMA 174:966–971PubMed
13.
Houssiau FA, N’Zeusseu Toukap A, Depresseux G et al (1998) Magnetic resonance imaging-detected avascular osteonecrosis in systemic lupus erythematosus: lack of correlation with antiphospholipid antibodies. Br J Rheumatol 37:448–453PubMedCrossRef
14.
Mont MA, Glueck CJ, Pacheco IH, Wang P, Hungerford DS, Petri M (1997) Risk factors for osteonecrosis in systemic lupus erythematosus. J Rheumatol 24:654–662PubMed
15.
Nagasawa K, Ishii Y, Mayumi T et al (1989) Avascular necrosis of bone in systemic lupus erythematosus: possible role of haemostatic abnormalities. Ann Rheum Dis 48:672–676PubMed
16.
Smith FE, Sweet DE, Brunner CM, Davis JS 4th (1976) Avascular necrosis in SLE. An apparent predilection for young patients. Ann Rheum Dis 35:227–232PubMedCrossRef
17.
Bergstein JM, Wiens C, Fish AJ, Vernier RL, Michael A (1974) Avascular necrosis of bone in systemic lupus erythematosus. J Pediatr 85:31–35PubMedCrossRef
18.
Zizic TM, Marcoux C, Hungerford DS, Dansereau JV, Stevens MB (1985) Corticosteroid therapy associated with ischemic necrosis of bone in systemic lupus erythematosus. Am J Med 79:596–604PubMedCrossRef
19.
Love PE, Santoro SA (1990) Antiphospholipid antibodies: anticardiolipin and lupus anticoagulant in systemic lupus erythematosus (SLE) and non-SLE disorders. Ann Intern Med 112:682–697PubMed
20.
Ninomiya C, Taniguchi O, Kato T et al (1992) Distribution and clinical significance of lupus anticoagulant and anticardiolipin antibody in 349 patients with systemic lupus erythematosus. Intern Med 31:194–199PubMed
21.
de Brandt M, Benali K, Guillevin L et al (1999) Longitudinal determination of antiphospholipid antibodies in lupus patients without previous manifestations of antiphospholipid syndrome. A prospective study. J Rheumatol 26:91–96
22.
Asherson RA, Liote F, Page B (1993) Avascular necrosis of bone and antiphospholipid antibodies in systemic lupus erythematosus. J Rheumatol 20:284–288PubMed
23.
Mok CC, Lau CS, Wong RW (1998) Risk factors for avascular bone necrosis in systemic lupus erythematosus. Br J Rheumatol 37:895–900PubMedCrossRef
24.
Migliaresi S, Picillo U, Ambrosone L et al (1994) Avascular osteonecrosis in patients with SLE: relation to corticosteroid therapy and anticardiolipin antibodies. Lupus 3:37–41PubMed
25.
Goorney BP, Lacey H, Thurairajasingam S, Brown JD (1990) Avascular necrosis of the hip in a man with HIV infection. Genitourin Med 66:451–452PubMed
26.
Rademaker J, Dobro JS, Solomon G (1997) Osteonecrosis and human immunodeficiency virus infection. J Rheumatol 24:601–604PubMed
27.
Miller KD, Masur H, Jones EC et al (2002) High prevalence of osteonecrosis of the femoral head in HIV-infected adults. Ann Intern Med 137:17–25PubMed
28.
Ramos-Casals M, Cervera R, Lagrutta M et al (2004) Clinical features related to antiphospholipid syndrome in patients with chronic viral infections (hepatitis C virus/HIV infection): description of 82 cases. Clin Infect Dis 38:1009–1016PubMedCrossRef
29.
Jones LC, Mont MA, Le TB et al (2003) Procoagulants and osteonecrosis. J Rheumatol 30:783–791PubMed
30.
Glueck CJ, Crawford A, Roy D, Freiberg R, Glueck H, Stroop D (1996) Association of antithrombotic factor deficiencies and hypofibrinolysis with Legg–Perthes disease. J Bone Joint Surg Am 78:3–13PubMed
31.
Gallistl S, Reitinger T, Linhart W, Muntean W (1999) The role of inherited thrombotic disorders in the etiology of Legg–Calve–Perthes disease. J Pediatr Orthop 19:82–83PubMedCrossRef
32.
Ura Y, Hara T, Mori Y et al (1992) Development of Perthes’ disease in a 3-year-old boy with idiopathic thrombocytopenic purpura and antiphospholipid antibodies. Pediatr Hematol Oncol 9:77–80PubMed
33.
Courtney AE, McDonnell GV, Patterson VH (2001) Human immunoglobulin for diabetic amyotrophy—a promising prospect? Postgrad Med J 77:326–328PubMedCrossRef
34.
Gruppo R, Glueck CJ, McMahon RE et al (1996) The pathophysiology of alveolar osteonecrosis of the jaw: anticardiolipin antibodies, thrombophilia, and hypofibrinolysis. J Lab Clin Med 127:481–488PubMedCrossRef
35.
Alijotas J, Argemi M, Barquinero J (1990) Kienbock’s disease and antiphospholipid antibodies. Clin Exp Rheumatol 8:297–298PubMed
36.
Yoo WH (2004) Multiple rib infarcts: a rare form of osteonecrosis in antiphospholipid syndrome. Ann Rheum Dis 63:457–458PubMedCrossRef
37.
Mok MY, Isenberg DA (2000) Avascular necrosis of a single vertebral body, an atypical site of disease in a secondary APLS. Ann Rheum Dis 59:494–495PubMedCrossRef
38.
Egan RM, Munn RK (1994) Catastrophic antiphospholipid antibody syndrome presenting with multiple thromboses and sites of avascular necrosis. J Rheumatol 21:2376–2379PubMed
39.
Cervera R, Font J, Gomez-Puerta JA et al (2005) Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome. Ann Rheum Dis 64:1205–1209PubMedCrossRef
40.
Bulvik S, Aronson I, Ress S, Jacobs P (1995) Extensive bone marrow necrosis associated with antiphospholipid antibodies. Am J Med 98:572–574PubMedCrossRef
41.
Paydas S, Koçak R, Zorludemir S, Baslamisli F (1997) Bone marrow necrosis in antiphospholipid syndrome. J Clin Pathol 50:261–262PubMedCrossRef
42.
Murphy PT, Sivakumaran M, Casey MC, Liddicoat A, Wood JK (1998) Lymphoma associated bone marrow necrosis with raised anticardiolipin antibody. J Clin Pathol 51:407–409PubMedCrossRef
43.
Sinha J, Chowdhry I, Sedan S, Barland P (2002) Bone marrow necrosis and refractory HELLP syndrome in a patient with catastrophic antiphospholipid antibody syndrome. J Rheumatol 29:195–197PubMed
44.
Schaar CG, Ronday KH, Boets EP, van der Lubbe PA, Breedveld FC (1999) Catastrophic manifestation of the antiphospholipid syndrome. J Rheumatol 26:2261–2264PubMed
45.
Spyropoulos AC (1999) Membranous obstruction of the inferior vena cava and extensive bone marrow necrosis associated with catastrophic antiphospholipid syndrome. J Clin Rheumatol 5:279–284CrossRefPubMed
46.
Thuerl C, Altehoefer C, Spyridonidis A, Laubenberger J (2002) Imaging findings in the rare catastrophic variant of the primary antiphospholipid syndrome. Eur Radiol 12:545–548PubMed
47.
Moore J, Ma DD, Concannon A (1998) Non-malignant bone marrow necrosis: a report of two cases. Pathology 30:318–320PubMedCrossRef
48.
Sangle S, D’Cruz DP, Khamashta MA, Hughes GR (2004) Antiphospholipid antibodies, systemic lupus erythematosus, and non-traumatic metatarsal fractures. Ann Rheum Dis 63:1241–1243PubMedCrossRef
49.
Paran D, Segal R, Jukovsky G, Fishel B, Yaron M (1996) Transient regional osteoporosis with antiphospholipid antibodies: a report of two cases. Clin Exp Rheumatol 14:677–680PubMed
50.
Eulry F, Bauduceau B, Clement R et al (1987) Algodystrophy and venous thrombosis of the lower extremities. Diagnostic discussion. Apropos of 3 cases. Phlebologie 40:251–259PubMed
51.
Eulry F, Chazerain P, Magnin J et al (1989) Algodystrophy and venous thrombosis of the lower limbs: diagnostic problems. Apropos of 5 cases. Rev Rhum Mal Osteoartic 56:403–407PubMed
52.
Tsutsumi A, Horita T, Ohmuro J et al (1999) Reflex sympathetic dystrophy in a patient with the antiphospholipid syndrome. Lupus 8:471–473PubMedCrossRef
53.
Palmer GW, Greco TP (2001) Diabetic thigh muscle infarction in association with antiphospholipid antibodies. Semin Arthritis Rheum 30:272–280PubMedCrossRef
Metadata
Title
Orthopedic Involvement in Antiphospholipid Syndrome
Authors
Alexander Gorshtein
Yair Levy
Publication date
01-04-2007
Publisher
Humana Press Inc
Published in
Clinical Reviews in Allergy & Immunology / Issue 2/2007
Print ISSN: 1080-0549
Electronic ISSN: 1559-0267
DOI
https://doi.org/10.1007/s12016-007-0006-y

Other articles of this Issue 2/2007

Clinical Reviews in Allergy & Immunology 2/2007 Go to the issue

OriginalPaper

Looking Into the Eyes of Patients with Antiphospholipid Syndrome

OriginalPaper

Antiphospholipid Syndrome and Cancer

OriginalPaper

The Heart and APS

OriginalPaper

APS—More Systemic Disease than SLE

OriginalPaper

Antiphospholipid Syndrome and Cognition

OriginalPaper

Clinical Thrombotic Manifestations in SLE Patients With and Without Antiphospholipid Antibodies: A 5-year Follow-up
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits